The Economic Times

SC grills Sebi over lingering probe against Sandesara brothers despite Rs 5,100 cr settlement

In a surprising turn of events, the Supreme Court has scrutinised Sebi's ongoing actions against the directors of Sterling Biotech. This review arises following the directors hefty 5,100 crore settlement payment. Earlier, the court had invalidated all related cases. Sebi's investigation concerns the suspected routing of funds.